Both in Biotechnology
ImmunityBio vs Repligen
Over the past year IBRX returned +245.4% and RGEN returned +18.7%; their daily moves had a correlation of 0.17.
IBRX +245.4% RGEN +18.7%Growth of $1, one year, split-adjusted
| Metric | IBRX | RGEN |
|---|---|---|
| Price | $8.29 | $176.94 |
| Market cap | $8.79B | $11.23B |
| Today | −5.15% | −6.20% |
| 1 month | −10.7% | −0.2% |
| 6 months | +16.6% | +51.0% |
| Year to date | +318.7% | +8.0% |
| 1 year | +242.6% | +19.2% |
| Revenue growth (YoY) | +93.9% | +10.9% |
| Gross margin | 99.4% | 53.0% |
| Net margin | −449.6% | −18.4% |
| P/E (TTM) | — | — |
| Price / sales | 53.0× | 13.9× |
| Net cash | -$57.7M | $307.4M |
| Dividend yield | — | — |
| Volatility (60d) | 68.0% | 47.0% |
| Short % of float | 31.1% | 12.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).